Sales and Marketing

Showing 15 posts of 11520 posts found.

shutterstock_38078521

Tonix plunges 68% after PTSD drug failure

July 30, 2018 Research and Development, Sales and Marketing PTSD, Tonmya, pharma, tonix

Tonix Pharmaceuticals has announced that it has terminated its Phase 3 study of Tonmya (cyclobenzaprine HCl sublingual tablets) in military-related …
British army soldier marching

Army to ferry medicines in case of no-deal Brexit

July 30, 2018 Sales and Marketing UK, army, brexit, medicines, pharma, politics, supply chains

Ministers have established plans to use the army to deliver medicines, food and fuel in the event of a no-deal …
sean-harper

Amgen announces resignation of two top executives

July 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Anthony C Cooper, R&D, biotech, retire, sean harper

Amgen’s head of R&D, Dr Sean Harper, has announced that he is retiring from his current position as Executive Vice …

Gilead’s CEO and Chairman to both step down before year’s end

July 26, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma

Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …

AstraZeneca announces price freezes while earnings drop by 28%

July 26, 2018 Business Services, Sales and Marketing AstraZeneca, Trump, price freezes, price hikes

The Anglo-Swedish drug maker AstraZeneca has joined Pfizer and others in halting price hikes until the end of 2018. AstraZeneca …
Matt Hancock

NHS to stockpile drugs in preparation for no-deal Brexit

July 25, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, brexit, government, pharma, stockpiling

Secretary of State for Health and Social Care, Matt Hancock, has said that the NHS is preparing to stockpile medicines …

FDA approves first endometriosis pain management drug in a decade

July 25, 2018 Research and Development, Sales and Marketing AbbVie, FDA, Neurocrine Biosciences, endometriosis, pharma

The FDA has confirmed its approval of AbbVie and Neurocrine Biosciences’ Orilissa (elagolix), a nonpeptide small molecule gonadotropin-releasing hormone (GnRH) …
stana-moisescu-appointment

Teva Romania announces new general manager

July 24, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Israeli multinational Teva Pharmaceuticals have announced the appointment of Stana Moisescu as the General Director of Teva Romania, the company’s …
astrazeneca_plaque

AstraZeneca jettisons European heart drug rights for $210m

July 24, 2018 Manufacturing and Production, Sales and Marketing AstraZeneca, Atacand, Cheplapharm, blood pressure, heart failure, pharma

AstraZeneca has announced its intention to hand over the European commercial rights to its heart failure and blood pressure treatment …
512px-antibiotic_sensitvity_and_resistance

The mission against antimicrobial resistance

July 23, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance, antimicrobial resistance, feature, pharma

Two headlines have highlighted the ‘here and now’ of the threat of rising antimicrobial resistance (AMR), writes Dr Peter Jackson.A …

FDA approves Agios’ oral leukaemia treatment Tibsovo

July 23, 2018 Sales and Marketing FDA, agios, approval, pharmaceuticals, tibsovo

The oral leukaemia treatment Tibsovo (ivosidenib) produced by Massachusetts-based Agios Pharmaceuticals has been approved for treatment of adult patients with …
allergan

US court overturns Allergan’s controversial attempts to avoid Restasis patent review

July 23, 2018 Sales and Marketing Allergan, Mylan, Restasis, US, dry eye, pharma

The US Court of Appeals for the Federal Circuit has seen fit to authorise a US Patent and Trademark Office …
The Gateway to Local Adoption Series

Latest content